DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

MedPlus Q2 Results: Net profit flat as revenue surges 21%; store-level ROCE at 72%

CNBC-TV18 57 min ago·27 Oct 2026, 1:43 pm

MedPlus Health Services reported a marginal 0.9% year-on-year rise in Q2 FY27 net profit to ₹56 crore, despite a 21.3% increase in revenue to ₹2,037 crore. EBITDA grew 14.1% to ₹170 crore, but the EBITDA margin narrowed to 8.4% from 8.9% a year earlier. The pharmacy retail chain added 166 stores on a net basis during the quarter, taking its total store count to 5,642 as of September 30, 2026.